MedWatch

Genmab nominates Eli Lilly veteran as board member

Genmab has nominated a successor to Jonathan Peacock, who stepped down from the company’s board of directors last year. The appointee is a woman with more than 24 years of experience at Eli Lilly.

Photo: Joost Melis / Genmab / PR

Genmab proposes Elizabeth O’Farrell be elected as a member of the board of directors at the company’s upcoming annual general meeting on March 29, a press release announces.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs